Company Profile

Rational Affinity Devices LLC (AKA: RAD)
Profile last edited on: 8/4/11      CAGE: 46W11      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2004
First Award
2006
Latest Award
2009
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

211 Warren Street
Newark, NJ 07103
   (732) 470-6970
   N/A
   www.rationalaffinity.com
Location: Single
Congr. District: 10
County: Essex

Public Profile

Rational Affinity Devices, LLC delivers cost-effective, technology-based solutions to the life science market through the development of patented innovative, accurate and reliable methods of molecular purification, detection and analysis. The work represents a paradigm shift in methods of detection and processing target molecules through the use of "tunable" affinity ligands A team of inter-disciplinary scientists and partners have designed a unique set of forward-thinking diagnostic products geared to addressing the research and testing needs of the evolving use of biologicals in the marketplace. RAD’s approach toward resolution of market needs involves the application of rational design principles to the engineering of molecules with properties amenable to industry, physician and consumer diagnostic products. These principles are being used to develop: the gentlest possible methods for isolating and separating functionally active biological molecules from complex mixtures, and highly quantitative detection methods for ultra-specific molecular, bacterial and cellular analysis. RAD has developed enabling technology to increase both the analytical and biological selectivity of assays designed to discriminate structurally and functionally similar molecules

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 2 NIH $606,250
Project Title: Self-Reporting Arrays For Rapid, Robust And Precise S. Aureus Diagnostics
2006 1 NIH $133,596
Project Title: Quantitative Self-Reporting Arrays for miRNA Profiling
2006 1 NSF $99,997
Project Title: Quantitative Self-Reporting Arrays for Micro RNA (miRNA) Profiling

Key People / Management

  Les Beadling -- President and CEO

Company News

There are no news available.